$NEON
Neonode Inc Stock $neon

$neon Overview Financials Valuation SEC Filings Company Website

2015 Q1 Form 10-Q Financial Statement

#000121390015003300 Filed on May 06, 2015

Income Statement

Concept	2015 Q1	2014 Q1	2011 Q4
Revenue	$2.263M	$1.014M	$3.960M
YoY Change	123.18%	85.04%	4850.0%
Cost Of Revenue	$338.0K	$166.0K	$180.0K
YoY Change	103.61%	937.5%	200.0%
Gross Profit	$1.925M	$848.0K	$3.780M
YoY Change	127.0%	59.4%	12500.0%
Gross Profit Margin	85.06%	83.63%	95.45%
Selling, General & Admin	$2.412M	$3.071M	$1.920M
YoY Change	-21.46%	24.99%	-20.66%
% of Gross Profit	125.3%	362.15%	50.79%
Research & Development	$1.579M	$1.784M	$820.0K
YoY Change	-11.49%	9.18%	-19.61%
% of Gross Profit	82.03%	210.38%	21.69%
Depreciation & Amortization	$51.00K	$41.00K	$10.00K
YoY Change	24.39%	28.13%
% of Gross Profit	2.65%	4.83%	0.26%
Operating Expenses	$3.991M	$4.855M	$2.730M
YoY Change	-17.8%	18.68%	-20.41%
Operating Profit	-$2.066M	-$4.007M	$1.050M
YoY Change	-48.44%	12.59%	-130.88%
Interest Expense	$4.000K	-$30.00K	-$3.770M
YoY Change	-113.33%	-25.0%	18750.0%
% of Operating Profit			-359.05%
Other Income/Expense, Net	$4.000K
YoY Change
Pretax Income	-$2.070M	-$4.007M	-$2.720M
YoY Change	-48.34%	12.59%	-61.09%
Income Tax	$2.000K	$1.000K	$50.00K
% Of Pretax Income
Net Earnings	-$2.072M	-$4.008M	-$2.770M
YoY Change	-48.3%	12.27%	-60.65%
Net Earnings / Revenue	-91.56%	-395.27%	-69.95%
Basic Earnings Per Share
Diluted Earnings Per Share	-$511.1K	-$1.058M	-$948.6K
COMMON SHARES
Basic Shares Outstanding	40.46M shares	37.94K shares	27.93M shares
Diluted Shares Outstanding		37.94M shares

Balance Sheet

Concept	2015 Q1	2014 Q1	2011 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.450M	$6.190M	$12.94M
YoY Change	-28.11%	-18.34%	1321.98%
Cash & Equivalents	$4.453M	$6.192M	$12.94M
Short-Term Investments
Other Short-Term Assets	$1.150M	$1.600M	$29.00K
YoY Change	-28.13%	119.18%	-81.88%
Inventory
Prepaid Expenses
Receivables	$2.041M	$655.0K	$3.345M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$7.643M	$8.440M	$16.52M
YoY Change	-9.44%	-7.51%	1246.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$554.0K	$340.0K	$108.0K
YoY Change	62.94%	3.66%	350.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets		$10.00K
YoY Change		-85.71%
Total Long-Term Assets	$554.0K	$348.0K	$108.0K
YoY Change	59.2%	-12.12%	350.0%
TOTAL ASSETS
Total Short-Term Assets	$7.643M	$8.440M	$16.52M
Total Long-Term Assets	$554.0K	$348.0K	$108.0K
Total Assets	$8.197M	$8.788M	$16.63M
YoY Change	-6.73%	-7.7%	1229.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$735.0K	$425.0K	$447.0K
YoY Change	72.94%	32.4%	1.13%
Accrued Expenses	$1.143M	$1.167M	$601.0K
YoY Change	-2.06%	18.6%	-6.53%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Long-Term Debt Due	$60.00K
YoY Change
Total Short-Term Liabilities	$6.080M	$5.305M	$2.954M
YoY Change	14.61%	25.56%	-73.42%
LONG-TERM LIABILITIES
Long-Term Debt	$320.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$320.0K	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.080M	$5.305M	$2.954M
Total Long-Term Liabilities	$320.0K	$0.00	$0.00
Total Liabilities	$6.399M	$5.305M	$2.954M
YoY Change	20.62%	25.56%	-73.42%
SHAREHOLDERS EQUITY
Retained Earnings	-$168.0M	-$155.7M	-$129.3M
YoY Change	7.9%	9.51%	15.28%
Common Stock	$40.00K	$38.00K	$33.00K
YoY Change	5.26%	11.76%	-99.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.798M	$3.483M	$13.67M
YoY Change
Total Liabilities & Shareholders Equity	$8.197M	$8.788M	$16.63M
YoY Change	-6.73%	-7.7%	1229.1%

Cashflow Statement

Concept	2015 Q1	2014 Q1	2011 Q4
OPERATING ACTIVITIES
Net Income	-$2.072M	-$4.008M	-$2.770M
YoY Change	-48.3%	12.27%	-60.65%
Depreciation, Depletion And Amortization	$51.00K	$41.00K	$10.00K
YoY Change	24.39%	28.13%
Cash From Operating Activities	-$1.585M	-$2.646M	-$2.020M
YoY Change	-40.1%	59.11%	16.09%
INVESTING ACTIVITIES
Capital Expenditures	$3.000K	$46.00K	-$50.00K
YoY Change	-93.48%	-264.29%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$3.000K	-$46.00K	-$50.00K
YoY Change	-93.48%	64.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$14.00K	$36.00K	10.79M
YoY Change	-138.89%	-78.44%	355.27%
NET CHANGE
Cash From Operating Activities	-$1.585M	-$2.646M	-2.020M
Cash From Investing Activities	-$3.000K	-$46.00K	-50.00K
Cash From Financing Activities	-$14.00K	$36.00K	10.79M
Net Change In Cash	-$1.602M	-$2.656M	8.720M
YoY Change	-39.68%	74.28%	1284.13%
FREE CASH FLOW
Cash From Operating Activities	-$1.585M	-$2.646M	-$2.020M
Capital Expenditures	$3.000K	$46.00K	-$50.00K
Free Cash Flow	-$1.588M	-$2.692M	-$1.970M
YoY Change	-41.01%	64.65%	13.22%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015Q1	dei	Entity Registrant Name EntityRegistrantName	Neonode, Inc
CY2015Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000087050
CY2015Q1	dei	Amendment Flag AmendmentFlag	false
CY2015Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015Q1	dei	Document Type DocumentType	10-Q
CY2015Q1	dei	Document Period End Date DocumentPeriodEndDate	2015-03-31
CY2015Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2015Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40455352	shares
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8815000	usd
CY2014Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6192000	usd
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6129000	usd
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4453000	usd
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1106000	usd
CY2015Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2041000	usd
CY2014Q4	us-gaap	Investments In Power And Distribution Projects InvestmentsInPowerAndDistributionProjects	200000	usd
CY2015Q1	us-gaap	Investments In Power And Distribution Projects InvestmentsInPowerAndDistributionProjects	613000	usd
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	513000	usd
CY2015Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	536000	usd
CY2014Q4	us-gaap	Assets Current AssetsCurrent	7948000	usd
CY2015Q1	us-gaap	Assets Current AssetsCurrent	7643000	usd
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	654000	usd
CY2015Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	554000	usd
CY2014Q4	us-gaap	Assets Assets	8602000	usd
CY2015Q1	us-gaap	Assets Assets	8197000	usd
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	566000	usd
CY2015Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	735000	usd
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	935000	usd
CY2015Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1143000	usd
CY2014Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3403000	usd
CY2015Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	4146000	usd
CY2014Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	61000	usd
CY2015Q1	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	56000	usd
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4965000	usd
CY2015Q1	us-gaap	Liabilities Current LiabilitiesCurrent	6080000	usd
CY2014Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	367000	usd
CY2015Q1	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	319000	usd
CY2014Q4	us-gaap	Liabilities Liabilities	5332000	usd
CY2015Q1	us-gaap	Liabilities Liabilities	6399000	usd
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2015Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2015Q1	us-gaap	Common Stock Value CommonStockValue	40000	usd
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	169010000	usd
CY2015Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	169608000	usd
CY2014Q4	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	149000	usd
CY2015Q1	us-gaap	Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax	151000	usd
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-165929000	usd
CY2015Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-168001000	usd
CY2011Q4	us-gaap	Stockholders Equity StockholdersEquity	13673000	usd
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	8100000	usd
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	6348000	usd
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	3270000	usd
CY2015Q1	us-gaap	Stockholders Equity StockholdersEquity	1798000	usd
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8602000	usd
CY2015Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8197000	usd
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2015Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	70000000	shares
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40455352	shares
CY2015Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40455352	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40455352	shares
CY2015Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40455352	shares
CY2014Q1	us-gaap	Revenues Revenues	1014000	usd
CY2015Q1	us-gaap	Revenues Revenues	2263000	usd
CY2014Q1	us-gaap	Cost Of Revenue CostOfRevenue	166000	usd
CY2015Q1	us-gaap	Cost Of Revenue CostOfRevenue	338000	usd
CY2014Q1	us-gaap	Gross Profit GrossProfit	848000	usd
CY2015Q1	us-gaap	Gross Profit GrossProfit	1925000	usd
CY2014Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1784000	usd
CY2015Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1579000	usd
CY2014Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1042000	usd
CY2015Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	850000	usd
CY2014Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2029000	usd
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1562000	usd
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	4855000	usd
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	3991000	usd
CY2014Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-4007000	usd
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2066000	usd
CY2014Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2015Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	4000	usd
CY2014Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense		usd
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4000	usd
CY2014Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-4007000	usd
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-2070000	usd
CY2014Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1000	usd
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2000	usd
CY2014Q1	us-gaap	Net Income Loss NetIncomeLoss	-4008000	usd
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	-2072000	usd
CY2014Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2015Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.05
CY2014Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37941	shares
CY2015Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40455	shares
CY2014Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	35000	usd
CY2015Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	2000	usd
CY2014Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3973000	usd
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2070000	usd
CY2014Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1072000	usd
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	598000	usd
CY2014Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	41000	usd
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51000	usd
CY2014Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-314000	usd
CY2015Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	935000	usd
CY2014Q1	neond	Increase Decrease In Projects In Process IncreaseDecreaseInProjectsInProcess	202000	usd
CY2015Q1	neond	Increase Decrease In Projects In Process IncreaseDecreaseInProjectsInProcess	417000	usd
CY2014Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	139000	usd
CY2015Q1	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	58000	usd
CY2014Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	228000	usd
CY2015Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	502000	usd
CY2014Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	48000	usd
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	746000	usd
CY2014Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2646000	usd
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1585000	usd
CY2014Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	46000	usd
CY2015Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3000	usd
CY2014Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-46000	usd
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3000	usd
CY2014Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	36000	usd
CY2015Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises		usd
CY2014Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations		usd
CY2015Q1	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	14000	usd
CY2014Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	36000	usd
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-14000	usd
CY2014Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	33000	usd
CY2015Q1	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-74000	usd
CY2014Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-2623000	usd
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-1676000	usd
CY2014Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	1000	usd
CY2015Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	2000	usd
CY2014Q1	us-gaap	Interest Paid InterestPaid		usd
CY2015Q1	us-gaap	Interest Paid InterestPaid	4000	usd
CY2014	us-gaap	Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount	1729000	usd
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6892000	usd
CY2014	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9253000	usd
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1060000	usd
CY2013	neond	Stock Option And Warrant Compensation Expense To Employees Directors And Vendors StockOptionAndWarrantCompensationExpenseToEmployeesDirectorsAndVendors	2656000	usd
CY2012	neond	Stock Issued During Period Value Employee Stock Option And Warrant Compensation Expense StockIssuedDuringPeriodValueEmployeeStockOptionAndWarrantCompensationExpense	3499000	usd
CY2012	neond	Common Stock Issued Upon Exercise Of Common Stock Warrants CommonStockIssuedUponExerciseOfCommonStockWarrants	223000	usd
CY2013	neond	Common Stock Issued Upon Exercise Of Common Stock Warrants CommonStockIssuedUponExerciseOfCommonStockWarrants	714000	usd
CY2014	neond	Common Stock Issued Upon Exercise Of Common Stock Warrants CommonStockIssuedUponExerciseOfCommonStockWarrants	36000	usd
CY2015Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><b><i>Estimates</i></b></font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"> </font></p> <p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">The preparation of financial statements in conformity with U.S. GAAP requires making estimates and assumptions that affect, at the date of the financial statements, the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities and the reported amounts of revenue and expenses. Actual results could differ from these estimates. Significant estimates include, but are not limited to, collectability of accounts receivable,the achievement of substantive milestones and vendor-specific objective evidence (“VSOE”) of fair value for purposes of revenue recognition (or deferral of revenue), recoverability of capitalized project costs and long-lived assets, the valuation allowance related to our deferred tax assets and the fair value of options and warrants issued for stock-based compensation.</font></p>
CY2015Q1	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><b><i>Concentration of Credit and Business Risks</i></b></font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our customers are located in U.S., Europe and Asia.</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As of March 31, 2015, one customer represented approximately 68% of the Company’s accounts receivable. </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">As of December 31, 2014, three customers represented approximately 87% of the Company’s accounts receivable. </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our net revenues for the three months ended March 31, 2015 were earned from twenty-four customers. Customers who accounted for 10% or more of our net revenues during the three months ended March 31, 2015 are as follows:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.5in; font-stretch: normal;"></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Hewlett Packard Company – 30%</font></td> </tr> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Amazon -28%</font></td> </tr> </table> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Our net revenues for the three months ended March 31, 2014 were earned from fourteen<font style="color: red;"> </font>customers. Customers who accounted for 10% or more of our net revenues during the three months ended March 31, 2014 are as follows:</font></p> <p style="font: 10pt/normal 'times new roman', times, serif; margin: 0px; color: #000000; text-transform: none; text-indent: 0.5in; letter-spacing: normal; word-spacing: 0px; white-space: normal; widows: 1; font-stretch: normal; -webkit-text-stroke-width: 0px;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"> </font></p> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.5in; font-stretch: normal;"></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Leap Frog – 30%</font></td> </tr> </table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.5in; font-stretch: normal;"></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Sony Corporation – 16%</font></td> </tr> </table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.5in; font-stretch: normal;"></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">Netronix Inc. – 14%</font></td> </tr> </table> <table style="font: 10pt/normal 'times new roman', times, serif; width: 1567px; text-transform: none; text-indent: 0px; letter-spacing: normal; word-spacing: 0px; border-collapse: collapse; widows: 1; font-size-adjust: none; font-stretch: normal; -webkit-text-stroke-width: 0px;" cellspacing="0" cellpadding="0"> <tr style="font: 10pt/normal 'times new roman', times, serif; vertical-align: top; font-stretch: normal;"> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.5in; font-stretch: normal;"></td> <td style="font: 10pt/normal 'times new roman', times, serif; width: 0.25in; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">●</font></td> <td style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;"><font style="font: 10pt/normal 'times new roman', times, serif; font-stretch: normal;">KOBO Inc. – 11%</font></td> </tr> </table> </div>
CY2015Q1	us-gaap	Revenue Recognition Deferred Revenue RevenueRecognitionDeferredRevenue	<p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-indent: 0px; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"><b><i>Deferred Revenues</i></b></font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 18pt;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;"> </font></p><p style="color: #000000; font-family: 'times new roman', times, serif; font-size: 10pt; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: normal; orphans: auto; text-align: start; text-transform: none; white-space: normal; widows: 1; word-spacing: 0px; -webkit-text-stroke-width: 0px; font-stretch: normal; margin: 0px; text-indent: 0.5in;"><font style="font-style: normal; font-variant: normal; font-weight: normal; font-stretch: normal; font-size: 10pt; line-height: normal; font-family: 'times new roman', times, serif;">From time-to-time we receive pre-payments from our customers related to future services or future license fee revenues. We defer the license fees until we have met all accounting requirements for revenue recognition as per unit royalty products are distributed and royalty reports are received. Engineering development fee revenues are deferred until such time as the engineering work has been completed and accepted by our customers.</font></p>
CY2014Q2	neond	Stock Issued During Period Shares Future Offering StockIssuedDuringPeriodSharesFutureOffering	5000000	shares
CY2015Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2015Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	50000000	krw
CY2015Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	10000000	jpy
CY2015Q1	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	100000	sek
CY2014Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	167000	usd
CY2015Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	167000	usd
CY2014	us-gaap	Environmental Costs Recognized Capitalized In Period EnvironmentalCostsRecognizedCapitalizedInPeriod	200000	usd
CY2015Q1	us-gaap	Environmental Costs Recognized Capitalized In Period EnvironmentalCostsRecognizedCapitalizedInPeriod	613000	usd
CY2014Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	26000	usd
CY2015Q1	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	26000	usd
CY2014Q1	us-gaap	Advertising Expense AdvertisingExpense	106000	usd
CY2015Q1	us-gaap	Advertising Expense AdvertisingExpense	20000	usd
CY2014Q1	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	6.46	pure
CY2015Q1	us-gaap	Foreign Currency Exchange Rate Translation1 ForeignCurrencyExchangeRateTranslation1	8.32	pure
CY2015Q1	neond	Excess Of Insurance Limits ExcessOfInsuranceLimits	4000000	usd
CY2014Q1	neond	Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss One WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLossOne	102.82	pure
CY2015Q1	neond	Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss One WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLossOne	119.15	pure
CY2014Q1	neond	Foreign Currency Exchange Rate Translation One ForeignCurrencyExchangeRateTranslationOne	119.93	pure
CY2015Q1	neond	Foreign Currency Exchange Rate Translation One ForeignCurrencyExchangeRateTranslationOne	119.63	pure
CY2015Q1	neond	Weighted Average Exchange Rate For The Consolidated Statement Of Operations And Of Comprehensive Loss Two WeightedAverageExchangeRateForTheConsolidatedStatementOfOperationsAndOfComprehensiveLossTwo	11.0000	pure
CY2014Q4	neond	Foreign Currency Exchange Rate Translation Two ForeignCurrencyExchangeRateTranslationTwo	10.9673	pure
CY2015Q1	neond	Foreign Currency Exchange Rate Translation Two ForeignCurrencyExchangeRateTranslationTwo	11.0497	pure
CY2014	neond	Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLoss	7.80	pure
CY2015Q1	neond	Weighted Average Exchange Rate For Statements Of Operations And Comprehensive Loss WeightedAverageExchangeRateForStatementsOfOperationsAndComprehensiveLoss	8.60	pure
CY2015Q1	neond	Number Of Customers NumberOfCustomers	24	customers
CY2015Q1	neond	Cash Central Insured Amount CashCentralInsuredAmount	3000000	usd
CY2015Q1	neond	Weighted Average Exchange Rate For The Consolidated Statement Of Operations And Of Comprehensive Loss Three WeightedAverageExchangeRateForTheConsolidatedStatementOfOperationsAndOfComprehensiveLossThree	31.56	pure
CY2015Q1	neond	Foreign Currency Exchange Rate Translation Three ForeignCurrencyExchangeRateTranslationThree	31.20	pure
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2014Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1072000	usd
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	598000	usd
CY2015Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	1180000	usd
CY2015Q1	neond	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Warrants Outstanding And Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsWarrantsOutstandingAndExercisableNumber	3335073	shares
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	265000	shares
CY2015Q1	neond	Share Based Compensation Arrangement By Sharebased Payment Award Options Vested Exercise Price ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedExercisePrice	4.15
CY2015Q1	neond	Share Based Compensation Arrangement By Sharebased Payment Award Options Vested Expire Date ShareBasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedExpireDate	2018-03-03
CY2015Q1	neond	Purchase Price Of Stock Options Per Share PurchasePriceOfStockOptionsPerShare	0.70
CY2015Q1	neond	Purchase Price Of Stock Options Amount PurchasePriceOfStockOptionsAmount	185500	usd
CY2015Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P2Y
CY2010Q1	neond	Nonrecurring Development Cost NonrecurringDevelopmentCost	500000	usd
CY2012Q4	neond	Nonrecurring Development Cost NonrecurringDevelopmentCost	500000	usd
CY2010Q1	neond	Description Of Development Cost Contributed DescriptionOfDevelopmentCostContributed	Under the terms of the NN1001 Agreement, we will reimburse TI an NRE fee of $0.08 per unit for each of the first one million units sold and $0.05 for the next eight million units sold.
CY2012Q4	neond	Description Of Development Cost Contributed DescriptionOfDevelopmentCostContributed	Under the terms of the NN1002 Agreement we will reimburse TI an NRE fee of $0.25 per unit for each of the first two million units sold.
CY2010Q1	neond	Nonrecurring Development Cost One NonrecurringDevelopmentCostOne	0.08
CY2010Q1	neond	Nonrecurring Development Cost Two NonrecurringDevelopmentCostTwo	0.05
CY2012Q4	neond	Non Recurring Development Cost Three NonRecurringDevelopmentCostThree	0.25
CY2014Q1	neond	Nonrecurring Expense Related To Agreement NonrecurringExpenseRelatedToAgreement	31000	usd
CY2015Q1	neond	Nonrecurring Expense Related To Agreement NonrecurringExpenseRelatedToAgreement	20000	usd
CY2015Q1	neond	Accounts Payable Under Agreement AccountsPayableUnderAgreement	81000	usd
CY2014Q1	neond	Revenue Percentage Net RevenuePercentageNet	1.00	pure
CY2015Q1	neond	Revenue Percentage Net RevenuePercentageNet	1.00	pure
CY2015Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37941	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	40455	shares

Files In Submission

Name	View Source	Status
0001213900-15-003300-index-headers.html	Edgar Link	pending
0001213900-15-003300-index.html	Edgar Link	pending
0001213900-15-003300.txt	Edgar Link	pending
0001213900-15-003300-xbrl.zip	Edgar Link	pending
f10q0315ex31ii_neonode.htm	Edgar Link	pending
f10q0315ex31i_neonode.htm	Edgar Link	pending
f10q0315ex32i_neonode.htm	Edgar Link	pending
f10q0315_neonode.htm	Edgar Link	pending
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
neond-20150331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
neond-20150331_cal.xml	Edgar Link	unprocessable
neond-20150331_def.xml	Edgar Link	unprocessable
neond-20150331_pre.xml	Edgar Link	unprocessable
neond-20150331_lab.xml	Edgar Link	unprocessable
neond-20150331.xml	Edgar Link	completed
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEON
Neonode Inc Stock $neon

2015 Q1 Form 10-Q Financial Statement

#000121390015003300 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEON Neonode Inc Stock $neon

2015 Q1 Form 10-Q Financial Statement

#000121390015003300 Filed on May 06, 2015

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEON
Neonode Inc Stock $neon